Literature DB >> 6820407

Four cases of hyperphenylalaninaemia: studies during pregnancy and of the offspring produced.

R Koch, M Blaskovics.   

Abstract

Four cases of variant hyperphenylalaninaemia during pregnancy are presented. Babies born to mothers with blood phenylalanine concentrations of 4-8 mg/dl were normal and did not exhibit significant microcephaly, although one did have a major congenital anomaly (exstrophy of the bladder). The mother with blood phenylalanine concentrations of 6-12 mg/dl during pregnancy delivered three of four infants with mild microcephaly but normal intellectual function. The data suggest that phenylalanine concentrations of 4-8 mg/dl are reasonable and desirable during pregnancy in hyperphenylalaninaemic women. Furthermore, the data do not support or refute the justification hypothesis of Bessman et al.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6820407     DOI: 10.1007/bf01799748

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  8 in total

1.  Atypical phenylketonuria in sisters with normal offspring.

Authors:  L I WOOLF; C OUNSTED; D LEE; M HUMPHREY; N M CHESHIRE; G R STEED
Journal:  Lancet       Date:  1961-08-26       Impact factor: 79.321

2.  Phenylalanine-hydroxylase activity in hyperphenylalaninaemia.

Authors:  P Justice; M E O'Flynn; D Y Hsia
Journal:  Lancet       Date:  1967-04-29       Impact factor: 79.321

3.  The problem of maternal phenylketonuria.

Authors:  R A MacCready; H L Levy
Journal:  Am J Obstet Gynecol       Date:  1972-05-01       Impact factor: 8.661

4.  Maternal phenylketonuria: implications for growth and development.

Authors:  W K Frankenburg; B R Duncan; R W Coffelt; R Koch; J G Coldwell; C D Son
Journal:  J Pediatr       Date:  1968-10       Impact factor: 4.406

5.  Maternal phenylketonuria.

Authors:  N P Forbes; K N Shaw; R Koch; R W Coffelt; R Straus
Journal:  Nurs Outlook       Date:  1966-01       Impact factor: 3.250

6.  Prenatal and postnatal developmental consequences of maternal phenylketonuria.

Authors:  R O Fisch; W A Walker; J A Anderson
Journal:  Pediatrics       Date:  1966-06       Impact factor: 7.124

7.  Management of maternal phenylketonuria: an emerging clinical problem.

Authors:  G M Komrower; I B Sardharwalla; J M Coutts; D Ingham
Journal:  Br Med J       Date:  1979-05-26

8.  Diet, genetics, and mental retardation interaction between phenylketonuric heterozygous mother and fetus to produce nonspecific diminution of IQ: evidence in support of the justification hypothesis.

Authors:  S P Bessman; M L Williamson; R Koch
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

  8 in total
  2 in total

1.  Maternal phenylketonuria.

Authors:  R Koch; E G Friedman; E Wenz; K Jew; C Crowley; G Donnell
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Maternal Phenylketonuria Collaborative Study (MPKUCS)--the 'outliers'.

Authors:  W B Hanley; C Azen; R Koch; K Michals-Matalon; R Matalon; B Rouse; F Trefz; S Waisbren; F de la Cruz
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.